Limit search to items available for checkout
E-REPORT
Title Guidance for industry [electronic resource] : IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer.
Imprint Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2004]

Copies/Volumes

LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE
Description 1 online resource (8 p.)
Note "Center for Biologics Evaluation and Research (CBER)."
"Clinical medical."
"Revision 1."
"January 2004."
Subject Medicine, Experimental -- Government policy -- United States.
Clinical trials -- Government policy -- United States.
Cancer -- Treatment -- United States.
Other Author Center for Drug Evaluation and Research (U.S.)
Center for Biologics Evaluation and Research (U.S.)
Other Title IND exemptions for studies of lawfully marketed drug or biological products for the treatment of cancer.